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Introduction: Kisspeptins, encoded by the Kiss1 gene, are a set of related neuropeptides that are required
for activation of the mammalian reproductive axis at puberty and to maintain fertility. In addition,
kisspeptin signaling via the G-protein coupled receptor GPR54 (KISS1R) has been suggested to regulate
human placental formation and correlations have been found between altered kisspeptin levels in the
maternal blood and the development of pre-eclampsia.
Methods: We have used Kiss1 and Gpr54mutant mice to investigate the role of kisspeptin signaling in the
structure and function of the mouse placenta.
Results: ExpressionofKiss1 andGpr54was conﬁrmed in themouseplacenta but nodifferences inbirthweight
were found in mice that had been supported by a mutant placenta during fetal development. Stereological
measurements found no differences between Kiss1mutant andwild-type placentas. Measurement of amino-
acid andglucose transport across theKiss1mutantplacentas atE15.5daysdidnot reveal any functionaldefects.
Discussion: These data indicate that mouse placentas can develop a normal structure and function
without kisspeptin signaling and can support normal fetal development and growth.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Kisspeptins, encoded by the Kiss1 gene, are a set of overlapping
neuropeptides that regulate the mammalian reproductive axis by
binding to the G-protein coupled receptor GPR54 (also known as
KISS1R) to stimulate GnRH secretion (for review see Ref. [1]. The
primary protein product of 138 amino-acids in humans is cleaved to
produce amidated peptides of different lengths including Kp54
(metastin), Kp14, Kp13 and Kp10 [2]. Kisspeptins were ﬁrst puriﬁed
from the human placenta, which has high levels of KISS1 expression
[2,3]. In the human placenta, kisspeptin is expressed by syncytio-
trophoblast cells [4e6] and kisspeptin levels in the maternal blood
increase considerably from the eighth week of pregnancy until
shortly after parturition [6,7]. The kisspeptin receptor, GPR54, is
also expressed by syncytiotrophoblasts, but also by villous and
extravillous cytotrophoblast cells. Kisspeptins inhibit migration of
the human extravillous trophoblast cell line HTR8SVneo [8] as well
as primary cultures of human trophoblast cells [4,9]. This reduced
trophoblast migration may be caused by reduced expression of
matrix metalloproteases [9] and/or increased adhesion to type I
collagen in the extracellular matrix [10].).
r Ltd. This is an open access articleThe inhibition of extravillous trophoblast migration has led to
the suggestion that kisspeptins may have a role in regulating
trophoblast invasion and placental development. Indeed,
abnormal kisspeptin signaling in humans is associated with
various pathologies of pregnancy, such as pre-eclampsia [11e16]
and impaired fetal growth [11,17]. It is not clear, however,
whether altered kisspeptin signaling is the primary cause of these
pathologies, or a secondary effect of abnormal placental develop-
ment. The aim of this study was to assess the expression of Kiss1
and Gpr54 in the murine placenta and analyze the structure and
function of Kiss1 mutant placentas to deﬁne any potential roles in
mouse placentation. We used Kiss1 mice rather than Gpr54 mice
for the structure/function studies to eliminate kisspeptin signaling
through both the GPR54 receptor and neuropeptide FF receptors
[18]. Although neuropeptide FF receptor expression has not been
described in the mouse placenta, it has been shown in human
placentas [19].2. Methods
2.1. Mouse lines
All animals were 129S6/Sv/Ev mice with targeted disruption of Gpr54 [20] or
Kiss1 [21]. The mice had ad-libitum access to food and water and a 12 h/12 h light/
dark cycle (7am to 7pm). All procedures were performed under authority of a Homeunder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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2.2. Timed matings
Gpr54 or Kiss1 heterozygous breeding pairs were set up to generate pregnant
females that carried fetuses and placentas of all three genotypes (wild-type, het-
erozygotes and homozygous mutants). Females were checked for vaginal plugs each
morning. On ﬁnding a plug the day was designated E0.5.
2.3. DNA isolation
2.3.1. DNA isolation from ear clips
After weaning, a small ear biopsy was placed in 150 ml of alkaline lysis reagent
(25 mM NaOH, 0.2 mM EDTA, pH 12). The sample was heated to 95 C for 1 h and
then cooled to 4 C. 150 ml of neutralization buffer (40 mM Tris-HCL, pH 5.0) was
added per tube. 1 ml of DNAwas used per 25 ml PCR immediately or stored at 20 C.
2.3.2. DNA isolation from yolk sac/embryonic tissue
The mother was killed and the uterus dissected out. The gestational age of the
embryos varied for each experiment and is stated in the methods and results sec-
tions for each experiment. Following dissection of the embryos, a small biopsy of
either yolk sac or embryonic tissue was washed with sterile PBS to avoid contami-
nation with maternal DNA before being placed in 100 ml of lysis buffer (50 mM KCl,
10 mM TriseHCl (pH 8.3), 2 mM MgCl2, 0.1 mg/ml gelatin, 0.45% Tween-20, 0.45%
Nonidet P40) and incubated at 55 C overnight. The sample was then heated to 94 C
for 15 min and 1 ml was used per PCR reaction or stored at 20 C.
2.4. Polymerase chain reaction (PCR) to analyze Kiss1 and Gpr54 expression
The PCR program used to genotype DNA from ear clips, yolk sacs and embryonic
tissue was as follows: an initial 5 min at 95 C followed by 44 cycles of 30 s at 93 C,
1 min at 60 C and 2 min at 70 C. The primer sequences were Kiss1: Forward e
tgctgcttctcctctgtgtcg; Reverse e gccgaaggagttccagttgta.
Gpr54: Forward e gccttcgcgctctacaacctgctg; Reverse e aaggcata
gagcagcggattgagc.
Agarose gel electrophoresis was used to size PCR products with a Hyperladder IV
DNA marker (Bioline, Cat no: Bio33029).
2.5. qRT-PCR analysis of Gpr54 and Kiss1 expression in E10.5 and E15.5 placentas
2.5.1. Tissue collection
Micewere killed and the placentas dissected out at the appropriate time point of
gestation. The placentas were rinsed in 1 PBS (pH 7.4) before being placed in
RNAlater (Qiagen; 76104). They were stored at 4 C overnight before being trans-
ferred to 80 C.
2.5.2. RNA extraction
RNA was extracted using RNeasy Plus Mini kit (Qiagen; 74134) according to the
manufacturer's instructions. RNAase-Free DNAase (Qiagen; 79254) was used to
ensure all genomic DNA had been removed. Gel electrophoresis was used to check
the integrity of the samples. The concentration of the samples was measured using a
NanoDrop 3300 spectrophotometer. Based on these results, equal concentrations of
RNA were converted into cDNA using SuperScript III Reverse Transcriptase (Invi-
trogen; 18080 044) according to the manufacturer's instructions.
2.5.3. Quantitative reverse transcriptase polymerase chain reaction using SYBR
green
A SensiMix Plus SYBR kit (Quantace; QT605) was used to prepare the reaction
mixture for quantitative PCR (qPCR). An ABI 7500 real-time thermal cycler was
programmed as follows; 95 C for 10 min followed by 40 cycles of 95 C for 15 s,
60 C for 15 s, 72 C for 15 s. The sequences of the primers were: Gapdh: Forward e
gatgcctgcttcaccacctcct; Reverse e aatgtgtccgtcgtggatctg.
Gpr54: Forward e tcactcggacccggatgtacaggtcag; Reverse e agcccg
cgtacctgctggatgtagttg.
Kiss1: Forward e ccgtcatccagcctaagtttctcac; Reverse e ataggtggc
gacacagaggagaagc.
A dissociation curve was added to conﬁrm the presence of a single product.
Serial dilutions (1, 1/5, 1/10, 1/50, 1/100) of cDNA were used with each primer pair.
RNA that had not been converted to cDNA (minus RT sample) was used to identify
genomic DNA contamination. Cycle threshold (Ct) values were plotted against log2
(template concentration) to analyze the efﬁciency of the primer pairs by calculating
the gradient of each slope.
2.5.4. Statistical analysis of qRT-PCR
The qRT-PCR data were analyzed using the 2DDCt method [22].
2.6. Placental transfer assays
Heterozygous crosses were set up and monitored for copulatory vaginal plugs.
The day of a plug was designated as E0.5. On E15.5 of pregnancy, unidirectionalmaterno-fetal clearance of the non-metabolizable radioactive tracers 14C-methyl-
isobutyric acid (MeAIB) and 3H-methyl D-glucose (MeG) were measured. Mice were
anaesthetized with fentanyl-ﬂuanisone (hypnorm): midazolam (hypnovel) in sterile
water (1:1:2). A 100 ml bolus of 3.5 mCi of MeAIB (NEN NEC-671; speciﬁc activity
1.86 Gbq/mmol, Perkin Elmer, USA) or MeG (NEN NEC-377; speciﬁc activity 2.1 Gbq/
mmol) in physiological saline (0.9% w/v) was injected intravenously into the
maternal jugular vein. At 2 min after the tracer injection the mother was killed by
cervical dislocation. Uteri were collected and the number of viable and resorbing
implantation sites were counted and fetal and placental weights were recorded.
Placental tissue was dissected into the Junctional and Labyrinthine zones and snap
frozen in liquid nitrogen for qRT-PCR analysis. The yolk sac was taken for geno-
typing. All fetuses were minced for counting radioactivity.
Minced fetuses were lysed at 55 C in Biosol (National Diagnostics, Atlanta, GA,
USA) before measuring beta emissions of known aliquots by liquid scintillation
counting (Optiphase Hisafe II, Perkin Elmer, USA; Packard Tri-carb, 1900, GMI Inc.
USA). Fetally accumulated radioactivity was used to calculate placental clearance of
MeAIB or MeG expressed as ml/min per gram of placenta. Counts accumulated in the
fetus were expressed as total fetal disintegrations per minute (DPM) per gram fetus.
2.7. Placental stereology
Heterozygous crosses were set up and monitored for vaginal plugs. At E15.5 the
female was killed and the uterus removed. Each fetus and its placenta was weighed.
The placentas were hemisected using a razor blade, the weight of each half was
recorded and they were then ﬁxed immediately.
2.7.1. Histology
The methods used here were based on Coan et al. [23]. Half of each placenta was
ﬁxed in 4% paraformaldehyde in 0.1 M PIPES buffer, dehydrated, and embedded in
parafﬁn wax. A vibrotome was used to vertically section the entire placental halves
into 7 mm thick sections. Systematic random sampling was used to select 10 sections
for analysis. Sections to be analyzed were stained using a standard hematoxylin and
eosin (H&E) protocol. The corresponding halves were ﬁxed for 6 h with 4% glutar-
aldehyde in 0.1 M PIPES buffer, washed with 0.1 M PIPES buffer, and treated with 1%
osmium tetroxide. The postﬁxed tissue was washed in 0.1 M PIPES buffer and
dehydrated. This was followed bywashes in propylene oxide, propylene oxide:Spurr
resin (1:1), and Spurr resin:propylene oxide (2:1), then overnight ﬂat embedding in
100% Spurr epoxy resin (Taab, Aldermaston, U.K.). Spurr resin was changed three
times over 3 days, and the castings were thermally cured at 608 C for 24 h. Sections,
1 mm thick, close to the placental midline were stained with Methylene blue.
2.7.2. Analysis
The Computer Assisted Stereology Toolbox (CAST) 2.0 system from Olympus
Ballerup, Denmark was used to perform all measurements.
2.7.3. Absolute placental volume
To determine the absolute volume of placentas, a 32-point grid was super-
imposed on vertically orientated parafﬁn sections viewed using a 1.25 objective
lens enabling a view of the complete sample. Points falling on the sample were
counted and the Cavalieri principle applied to reach a volume estimate:
Vobj ¼ t
X
a ¼ tap
X
P
where Vobj is the estimated placental volume, t is the total thickness of the placenta
(total number of sections multiplied by section thickness), ap is the area associated
with each point, and
P
P is the sum of points on sections.
2.7.4. Volume of placental zones
Using the 10 objective lens, 12 ﬁelds of view on the sections used for deter-
mining the absolute placental volume were selected by meander sampling and
measured by point counting to estimate component densities of the three zones (Lz,
Jz, and db) using the equation:
Vvðstruct;refÞ ¼ PðstructÞ
.
PðtotalÞ
where Vv(struct,ref) is the volume fraction of a component (e.g., labyrinth zone) within a
referencespace (e.g., placenta), P(struct) is thenumberofpoints fallingon the component,
and P(total) is the total number of points falling on the reference space (including the
component). The component volume densities obtained were converted to absolute
quantities by multiplying by total placental volume.
2.7.5. Labyrinth analyses
Resin sections were used to resolve the labyrinth vasculature in detail. A 100
objective lens was used and 12 ﬁelds of view within the labyrinth zone (Lz) were
selected by meander sampling to determine volume densities.
The maternal blood space (MBS) and fetal blood space (FBS) were identiﬁed
based on the appearance of the blood cells. Volume densities of the MBS, FBS, and
trophoblasts were obtained using a point grid. Volume densities were converted to
absolute component volumes by multiplying by the volume of the Lz.
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Details of statistical tests applied to each data set are given in the ﬁgure legends.
Statistical analyses of data were performed using InStat. P < 0.05 is considered
signiﬁcant.
3. Results
The birth weight of pups can provide an indicator of placental
function during gestation [24]. The birth weights of Gpr54 and Kiss1
mutant mice were compared to wild-type and heterozygous lit-
termates to assess whether mutant placentas compromised fetal
growth. As litter size is known to affect the birth weight of
individual animals, we separated the pups into small (5e8 pups)
and large (9e11 pups) litter groups as well as by sex (Fig. 1). The
genotype of the pups had no signiﬁcant effect on the average birth
weight suggesting that the absence of kisspeptin signaling in the
mouse placenta is not associated with compromised fetal growth.
In humans, decreased kisspeptin expression in trophoblast cells
during the ﬁrst trimester has been linked to recurrent pregnancy
loss [25], therefore birth rates were analyzed over a four year
period to see if there was evidence of increased in utero loss of
mutant mice (Fig. 2). Inheritance patterns conformed to the ex-
pected Mendelian inheritance ratios and no difference was found
between the Kiss1 and the Gpr54 mutant lines.
Expression of Gpr54 and Kiss1 was examined in wild-type pla-
centas at E10.5 and E15.5 by quantitative RT-PCR (Fig. 3). The data
show that both Gpr54 and Kiss1 are expressed in the mouse
placenta but Kiss1 mRNA levels are very low. Expression of both
Gpr54 and Kiss1 increased between E10.5 and E15.5 and expression
of Gpr54 was always higher than Kiss1 (Fig. 3).
Stereological analysis of the placentas was performed to inves-
tigate if there were any alterations in the size of each placental
zone. It was found that there were no differences in the volumes of
the different placental zones between wild-type and Kiss1 mutant
mice (Fig. 4A). Speciﬁcally, the volume of the labyrinth zone was
not altered in the Kiss1 mutant mice (Fig. 4C). A more detailed
stereological analysis of the labyrinth zone in Kiss1 mutant pla-
centas was performed. The area of trophoblast cells, and fetal and
maternal blood spaces was measured (Fig. 4B). No signiﬁcant dif-
ferences were found in the major structural components of the
labyrinth zone (Fig. 4D).
Fetal and placental weights and the ratio were measured as an
indicator of placental function and this showed that there was no
signiﬁcant difference between Kiss1 mutants and wild-type mice
(Fig. 5A). The stereological data suggest that nutrient transfer
across a mutant placenta should not be compromised but we per-
formed a functional test of amino-acid and glucose transport to
conﬁrm this. No alteration in the transport capacity of Kiss1mutant
placentas was found (Fig. 5B).
4. Discussion
We have examined Kiss1 mutant placentas in mice to establish
whether absence of kisspeptin signaling alters placental structure
or function. Although we detected both Gpr54 and Kiss1 expression
in the mouse placenta at E10.5 and E15.5, the level of Kiss1 tran-
scripts was very low. We did not ﬁnd any differences in the Kiss1
mutant placentas in the size of any of the placental zones or in the
cellular components of the labyrinth zone, which is the major re-
gion responsible for nutrient transfer across the placenta. Indeed,
measurement of amino-acid and glucose transport across Kiss1
mutant placentas did not reveal any defects which was consistent
with no reduction in the birth weight of the mutant pups. This data
suggests that kisspeptin signaling does not play a major role in
placental function in the mouse. One caveat however, is that sincewe used heterozygous females in these studies, our experiments
were not designed to identify any maternal factors that might in-
ﬂuence placental function such as uterine artery formation.
Our quantiﬁcation of Kiss1 and Gpr54 expression indicated that
Kiss1 transcripts were lower than Gpr54 in placentas at both E10.5
and E15.5 of gestation with Gpr54 transcripts at E15.5 being 300
greater than Kiss1 (Fig 3). This is in contrast to humans where Kiss1
mRNA is usually higher than Gpr54 [12,26,27] and in the rat, where
Kiss1 transcripts are around 20 greater than Gpr54 [28,29]. The
reason why Gpr54 transcripts were higher than Kiss1 in the mouse
is probably related to the extremely low expression of Kiss1 mRNA
in this species compared to other species. In the human placenta,
KISS1 is highly expressed at around 17% relative to GAPDH tran-
script levels which equates to 15,000 mRNA copies/ng mRNA [27].
In the rat placenta, Kiss1 expression is 20 mRNA copies/ng mRNA
[29] which represents around 0.02% of Gapdh expression which is
still sufﬁcient to be higher than Gpr54. We estimate that in the
E15.5 mouse placenta, Kiss1mRNA expression is around 0.000003%
compared to Gapdh, which makes the relative level of Gpr54 seem
very high. Consistent with this extremely low level of Kiss1 mRNA
expression, we have failed to detect either LacZ expression from the
targeted allele [21] or kisspeptin protein by immunohistochemistry
in mice (data not shown). Moreover, measurement of kisspeptin
protein in rat placentas shows a very low level of expression
(1.26 fmol/mg tissue) [30]. Clearly Kiss1 expression is considerably
higher in human placentas than in rodents. Indeed, elevated kiss-
peptin levels in the maternal blood analogous to those found in
pregnant women have not been reported in mice.
Our data suggest that kisspeptin signaling does not have a sig-
niﬁcant role in mouse placental structure or function. It is possible,
however, that the mutant placentas may be rescued by kisspeptin
production from heterozygous and wild-type littermates present in
the same uterus. We think that this is unlikely however given the
similar birthweights of the Kiss1 and Gpr54mutantmice. If absence
of kisspeptin signaling in the Kiss1 mutant placentas was being
rescued by kisspeptins produced by other placentas then we might
expect to see a difference speciﬁcally in the birth weights of the
Gpr54 mutant pups. A comparison of the birth weight of all of the
Gpr54 mutant pups of both sexes (n ¼ 21) with wild-type pups
(n ¼ 20) indicated no signiﬁcant difference between the average
birth weights. We are also not aware of any situation where the
phenotype of a mutant fetus has been rescued by trans-placental
movement of a secreted protein. For example, paternal trans-
mission of a mutated Igf-II allele which causes growth deﬁciency in
heterozygous placentas and fetuses is not prevented by IGF-II
secretion from adjacent wild-type placentas [31,32]. Moreover,
our qRT-PCR analysis indicates that the expression level of the Kiss1
gene in the mouse placenta is so low as to be of questionable
physiological signiﬁcance.
Although our data indicate that kisspeptin signaling is not
required for normal placentation in the mouse, it is likely that
kisspeptins will have additional roles in the mouse female repro-
ductive tract. For example, Calder et al. [33] have shown that
blastocyst implantation in Kiss1 null mice does not occur unless the
mice are injected with exogenous leukemia inhibitory factor (LIF)
suggesting that uterine kisspeptin signaling regulates LIF produc-
tion. The ability of embryo implantation to occur in Gpr54 null mice
where fertility has been rescued by restricted expression of a Gpr54
transgene in GnRH neurons [34] suggests that the kisspeptin in-
duction of LIF may be mediated by NPFF receptors rather than
GPR54. Alternatively, the Gpr54 transgene might be expressed in
the uterine epithelium of these rescued mice but this was not
examined by the authors. Kisspeptin signaling may also play a role
in oogenesis as Kiss1 and Gpr54 expression have been found in
ovarian tissue from rat, hamster and primates [35e37]. Recently,
Fig. 1. Weight of pups on day of birth compared with genotype and sex. A) Pups from Gpr54 large litters (n¼ 47). B) Pups from Gpr54 small litters (n¼ 41). C) Pups from Kiss1 large litters
(n¼ 57)D)Pups fromKiss1 small litters (n¼ 30).Meanvalues are shown. F, female;M,male. Therewasnostatistically signiﬁcantdifferencebetweenanyof thecategories (One-wayANOVA).
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related loss of ovarian follicles and develop premature ovarian
failure [38]. These studies indicate that kisspeptin signaling may
have roles in ovulation, implantation and pregnancy and furtherFig. 2. Analysis of the number of mice of each genotype born over a 4 year period.
P values were calculated using a Chi-squared test of the expected Mendelian fre-
quencies of all genotypes. There was no signiﬁcant deviation from the expected
numbers for each genotype.work will be needed to deﬁne these as well as identify possible
species differences.
Inwomen, placentally derived kisspeptin levels increase around
the eighth week of pregnancy and remain elevated throughout
gestation [6,7]. Reduced maternal serum kisspeptin levels betweenFig. 3. Expression analysis of Kiss1 and Gpr54 transcripts in the mouse placenta.
Transcript levels were measured by qRT-PCR at E10.5 and E15.5. There was a signiﬁcant
rise in both Gpr54 and Kiss1 expression between E10.5 (n ¼ 5) and E15.5 (n ¼ 5). P
values are shown (t-test).
Fig. 4. Structural analysis of Kiss1mutant placentas at E15.5. A) Low power photomicrographs of placentas illustrating the different zones. Lz ¼ Labyrinth zone, Jz ¼ junctional zone,
Db ¼ decidua basalis. Scale bar ¼ 1 mm. B) Identiﬁcation of components of the labyrinth vasculature. Fetal blood space (FBS), maternal blood space (MBS) and trophoblast cells
(Troph) were identiﬁed in the labyrinth zone. Scale bar ¼ 10 mM. C) Stereological measurement of the sizes of the placental zones in Kiss1 mutant placentas. 6 wild-type and 5 Kiss1
mutant placentas were analyzed. Bars indicate ± SEM. P > 0.05 (t-test). D) Comparison of the percentage volume of the labyrinth zone components. 6 wild-type and 5 Kiss1 mutant
placentas were analyzed using stereological methods. Bars indicate ± SEM. P > 0.05 (t-test).
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for-gestational age neonates [17]. It has also been reported that
decreasedmaternal serum kisspeptin levels in the second trimester
are associated with interuterine growth retardation [11]. Correla-
tions have also been observed between low maternal kisspeptin
levels during pregnancy and pre-eclampsia in humans [11e16]. It is
possible, therefore, that kisspeptin may have a role in humanplacental function but this is not required in themouse. It should be
noted however, that live individuals with mutations in GPR54 in-
dicates that kisspeptin signaling is not essential for the fetal part of
the placenta to form in humans. Moreover, the ability of women
with mutations in GPR54 to receive hormone treatments and
maintain a pregnancy to term shows that uterine expression of
GPR54 is also not essential for pregnancy [39]. What is not yet know
Fig. 5. Functional analysis of Kiss1mutant placentas at E15.5. A) Fetal and Placental weight parameters. Comparisons between wild-type and Kiss1mutant fetuses and placentas. 10
fetuses were analyzed in each category. All P > 0.05 (t-test). B) Relative amino acid and glucose transport across the placenta. At E15.5 of pregnancy unidirectional materno-fetal
clearance of the non-metabolizable radioactive tracers 14C-methyl-isobutyric acid (MeAIB) and 3H-methyl D-glucose (MeG) were measured. Fetally accumulated radioactivity was
used to calculate placental clearance of MeAIB and MeG. Placentas from 7 wild-type and 6 Kiss1 mutant mice were analyzed. Bars indicate ± SEM. P > 0.05 (t-test).
A.M. Herreboudt et al. / Placenta 36 (2015) 52e58 57is whether absence of GPR54 expression in both the uterus and the
fetus is compatible with normal placentation and fetal growth.
It is also possible however, that the reduced maternal kisspeptin
levels associated with fetal growth retardation or pre-eclampsia in
humans are secondary to a defect in placenta formation rather than
the primary cause. If this is the case, then kisspeptins would not
responsible for placental dysfunction in humans but could still be
used as a useful biomarker of placental function.
So far, the human data suggest a link between kisspeptin
signaling and placentation whereas our mouse data show that
kisspeptin signaling does not seem to play a major role in placen-
tation. Further investigations in humans are required to understand
if altered kisspeptin signaling has a direct role in placentation or if
altered kisspeptin signaling is a secondary effect of placental
dysfunction. Based on our ﬁndings, it is unlikely that themousewill
be a suitable model to investigate this further.Conﬂict of interest
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